HEADER TRANSFERASE 14-JAN-17 5UIT TITLE CRYSTAL STRUCTURE OF IRAK4 IN COMPLEX WITH COMPOUND 14 COMPND MOL_ID: 1; COMPND 2 MOLECULE: INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE 4; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 154-460; COMPND 5 SYNONYM: IRAK-4,RENAL CARCINOMA ANTIGEN NY-REN-64; COMPND 6 EC: 2.7.11.1; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: IRAK4; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS IRAK4, KINASE, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR S.HAN,J.S.CHANG REVDAT 2 26-JUL-17 5UIT 1 JRNL REVDAT 1 24-MAY-17 5UIT 0 JRNL AUTH K.L.LEE,C.M.AMBLER,D.R.ANDERSON,B.P.BOSCOE,A.G.BREE, JRNL AUTH 2 J.I.BRODFUEHRER,J.S.CHANG,C.CHOI,S.CHUNG,K.J.CURRAN,J.E.DAY, JRNL AUTH 3 C.M.DEHNHARDT,K.DOWER,S.E.DROZDA,R.K.FRISBIE,L.K.GAVRIN, JRNL AUTH 4 J.A.GOLDBERG,S.HAN,M.HEGEN,D.HEPWORTH,H.R.HOPE,S.KAMTEKAR, JRNL AUTH 5 I.C.KILTY,A.LEE,L.L.LIN,F.E.LOVERING,M.D.LOWE,J.P.MATHIAS, JRNL AUTH 6 H.M.MORGAN,E.A.MURPHY,N.PAPAIOANNOU,A.PATNY,B.S.PIERCE, JRNL AUTH 7 V.R.RAO,E.SAIAH,I.J.SAMARDJIEV,B.M.SAMAS,M.W.H.SHEN, JRNL AUTH 8 J.H.SHIN,H.H.SOUTTER,J.W.STROHBACH,P.T.SYMANOWICZ, JRNL AUTH 9 J.R.THOMASON,J.D.TRZUPEK,R.VARGAS,F.VINCENT,J.YAN,C.W.ZAPF, JRNL AUTH10 S.W.WRIGHT JRNL TITL DISCOVERY OF CLINICAL CANDIDATE JRNL TITL 2 1-{[(2S,3S,4S) JRNL TITL 3 -3-ETHYL-4-FLUORO-5-OXOPYRROLIDIN-2-YL]METHOXY}-7-METHOXYISO JRNL TITL 4 QUINOLINE-6-CARBOXAMIDE (PF-06650833), A POTENT, SELECTIVE JRNL TITL 5 INHIBITOR OF INTERLEUKIN-1 RECEPTOR ASSOCIATED KINASE 4 JRNL TITL 6 (IRAK4), BY FRAGMENT-BASED DRUG DESIGN. JRNL REF J. MED. CHEM. V. 60 5521 2017 JRNL REFN ISSN 1520-4804 JRNL PMID 28498658 JRNL DOI 10.1021/ACS.JMEDCHEM.7B00231 REMARK 2 REMARK 2 RESOLUTION. 1.84 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.9.6 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.84 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 59.29 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 89.7 REMARK 3 NUMBER OF REFLECTIONS : 59027 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.183 REMARK 3 R VALUE (WORKING SET) : 0.181 REMARK 3 FREE R VALUE : 0.218 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 3010 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.84 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.89 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 89.73 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 692 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2374 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 655 REMARK 3 BIN R VALUE (WORKING SET) : 0.2367 REMARK 3 BIN FREE R VALUE : 0.2502 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.35 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 37 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4502 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 50 REMARK 3 SOLVENT ATOMS : 454 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 31.51 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 41.71 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.43550 REMARK 3 B22 (A**2) : -3.66390 REMARK 3 B33 (A**2) : 4.09940 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.245 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.129 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.123 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.124 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.121 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.955 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.941 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 4672 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 6344 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1660 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 133 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 699 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 4672 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 604 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 43 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.02 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.94 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 17.05 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|* } REMARK 3 ORIGIN FOR THE GROUP (A): -27.7729 -31.9794 14.9603 REMARK 3 T TENSOR REMARK 3 T11: -0.1009 T22: -0.0557 REMARK 3 T33: -0.1295 T12: -0.0372 REMARK 3 T13: 0.0234 T23: 0.0022 REMARK 3 L TENSOR REMARK 3 L11: 1.7604 L22: 3.0590 REMARK 3 L33: 1.2170 L12: 1.2812 REMARK 3 L13: -0.0041 L23: 0.4836 REMARK 3 S TENSOR REMARK 3 S11: 0.2457 S12: -0.2188 S13: -0.0411 REMARK 3 S21: 0.3773 S22: -0.2721 S23: 0.1966 REMARK 3 S31: 0.0303 S32: -0.1433 S33: 0.0264 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: { B|* } REMARK 3 ORIGIN FOR THE GROUP (A): -12.0115 -25.1071 -16.0182 REMARK 3 T TENSOR REMARK 3 T11: -0.0658 T22: -0.0590 REMARK 3 T33: -0.1518 T12: 0.0187 REMARK 3 T13: -0.0198 T23: -0.0091 REMARK 3 L TENSOR REMARK 3 L11: 1.5231 L22: 2.2039 REMARK 3 L33: 1.4019 L12: -0.6437 REMARK 3 L13: -0.0963 L23: 0.2653 REMARK 3 S TENSOR REMARK 3 S11: 0.2005 S12: 0.1756 S13: -0.0247 REMARK 3 S21: -0.2806 S22: -0.1508 S23: 0.1245 REMARK 3 S31: -0.0559 S32: -0.0800 S33: -0.0496 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5UIT COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 18-JAN-17. REMARK 100 THE DEPOSITION ID IS D_1000225939. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-JAN-15 REMARK 200 TEMPERATURE (KELVIN) : 173 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 59046 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.840 REMARK 200 RESOLUTION RANGE LOW (A) : 90.380 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 90.2 REMARK 200 DATA REDUNDANCY : 5.700 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 17.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.39 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.58 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1.6-1.8 M AMMONIUM CITRATE, PH7.0, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 2 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X,Y,-Z REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z+1/2 REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 45.57000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 59.29000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 69.81500 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 45.57000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 59.29000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 69.81500 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 45.57000 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 59.29000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 69.81500 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 45.57000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 59.29000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 69.81500 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 138 REMARK 465 HIS A 139 REMARK 465 HIS A 140 REMARK 465 HIS A 141 REMARK 465 HIS A 142 REMARK 465 HIS A 143 REMARK 465 HIS A 144 REMARK 465 GLY A 145 REMARK 465 GLY A 146 REMARK 465 GLU A 147 REMARK 465 ASN A 148 REMARK 465 LEU A 149 REMARK 465 TYR A 150 REMARK 465 PHE A 151 REMARK 465 GLN A 152 REMARK 465 GLY A 153 REMARK 465 GLU A 154 REMARK 465 ASN A 155 REMARK 465 LYS A 156 REMARK 465 SER A 157 REMARK 465 LEU A 158 REMARK 465 GLU A 159 REMARK 465 VAL A 160 REMARK 465 SER A 161 REMARK 465 ALA A 216 REMARK 465 ALA A 217 REMARK 465 MET A 218 REMARK 465 VAL A 219 REMARK 465 ASP A 220 REMARK 465 ILE A 221 REMARK 465 GLU A 337 REMARK 465 LYS A 338 REMARK 465 PHE A 339 REMARK 465 ALA A 340 REMARK 465 GLN A 341 REMARK 465 ALA A 459 REMARK 465 SER A 460 REMARK 465 MET B 138 REMARK 465 HIS B 139 REMARK 465 HIS B 140 REMARK 465 HIS B 141 REMARK 465 HIS B 142 REMARK 465 HIS B 143 REMARK 465 HIS B 144 REMARK 465 GLY B 145 REMARK 465 GLY B 146 REMARK 465 GLU B 147 REMARK 465 ASN B 148 REMARK 465 LEU B 149 REMARK 465 TYR B 150 REMARK 465 PHE B 151 REMARK 465 GLN B 152 REMARK 465 GLY B 153 REMARK 465 GLU B 154 REMARK 465 ASN B 155 REMARK 465 LYS B 156 REMARK 465 SER B 157 REMARK 465 LEU B 158 REMARK 465 GLU B 159 REMARK 465 VAL B 160 REMARK 465 SER B 161 REMARK 465 ASP B 162 REMARK 465 THR B 163 REMARK 465 ALA B 217 REMARK 465 MET B 218 REMARK 465 VAL B 219 REMARK 465 ASP B 220 REMARK 465 ILE B 221 REMARK 465 GLU B 337 REMARK 465 LYS B 338 REMARK 465 PHE B 339 REMARK 465 ALA B 340 REMARK 465 GLN B 341 REMARK 465 ALA B 459 REMARK 465 SER B 460 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN A 228 CG CD OE1 NE2 REMARK 470 GLN B 228 CG CD OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE2 GLU B 402 OH TYR B 413 2.07 REMARK 500 O HOH A 637 O HOH A 763 2.09 REMARK 500 O HOH A 617 O HOH A 685 2.14 REMARK 500 O HOH B 688 O HOH B 797 2.15 REMARK 500 O HOH A 704 O HOH A 770 2.17 REMARK 500 O HOH A 670 O HOH A 735 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 OE2 GLU B 172 OE2 GLU B 172 4555 1.50 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 223 -96.13 81.67 REMARK 500 ARG A 310 -8.98 75.95 REMARK 500 ASP A 311 48.90 -140.97 REMARK 500 ASP A 329 85.43 65.21 REMARK 500 HIS A 390 10.34 -67.67 REMARK 500 LYS A 417 41.40 -86.35 REMARK 500 ASN B 206 -101.44 61.39 REMARK 500 THR B 223 -102.03 91.26 REMARK 500 ASP B 256 -155.98 84.71 REMARK 500 ARG B 310 -4.01 75.87 REMARK 500 ASP B 311 48.65 -147.81 REMARK 500 ASP B 329 83.22 70.00 REMARK 500 ASP B 405 31.09 -89.09 REMARK 500 GLU B 406 -175.28 38.67 REMARK 500 GLU B 407 -27.29 111.84 REMARK 500 LYS B 417 41.14 -85.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 833 DISTANCE = 6.54 ANGSTROMS REMARK 525 HOH A 834 DISTANCE = 6.70 ANGSTROMS REMARK 525 HOH B 819 DISTANCE = 6.01 ANGSTROMS REMARK 525 HOH B 820 DISTANCE = 6.54 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 8CD A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 8CD B 501 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5UIQ RELATED DB: PDB REMARK 900 RELATED ID: 5UIR RELATED DB: PDB REMARK 900 RELATED ID: 5UIS RELATED DB: PDB REMARK 900 RELATED ID: 5UIU RELATED DB: PDB DBREF 5UIT A 154 460 UNP Q9NWZ3 IRAK4_HUMAN 154 460 DBREF 5UIT B 154 460 UNP Q9NWZ3 IRAK4_HUMAN 154 460 SEQADV 5UIT MET A 138 UNP Q9NWZ3 INITIATING METHIONINE SEQADV 5UIT HIS A 139 UNP Q9NWZ3 EXPRESSION TAG SEQADV 5UIT HIS A 140 UNP Q9NWZ3 EXPRESSION TAG SEQADV 5UIT HIS A 141 UNP Q9NWZ3 EXPRESSION TAG SEQADV 5UIT HIS A 142 UNP Q9NWZ3 EXPRESSION TAG SEQADV 5UIT HIS A 143 UNP Q9NWZ3 EXPRESSION TAG SEQADV 5UIT HIS A 144 UNP Q9NWZ3 EXPRESSION TAG SEQADV 5UIT GLY A 145 UNP Q9NWZ3 EXPRESSION TAG SEQADV 5UIT GLY A 146 UNP Q9NWZ3 EXPRESSION TAG SEQADV 5UIT GLU A 147 UNP Q9NWZ3 EXPRESSION TAG SEQADV 5UIT ASN A 148 UNP Q9NWZ3 EXPRESSION TAG SEQADV 5UIT LEU A 149 UNP Q9NWZ3 EXPRESSION TAG SEQADV 5UIT TYR A 150 UNP Q9NWZ3 EXPRESSION TAG SEQADV 5UIT PHE A 151 UNP Q9NWZ3 EXPRESSION TAG SEQADV 5UIT GLN A 152 UNP Q9NWZ3 EXPRESSION TAG SEQADV 5UIT GLY A 153 UNP Q9NWZ3 EXPRESSION TAG SEQADV 5UIT MET B 138 UNP Q9NWZ3 INITIATING METHIONINE SEQADV 5UIT HIS B 139 UNP Q9NWZ3 EXPRESSION TAG SEQADV 5UIT HIS B 140 UNP Q9NWZ3 EXPRESSION TAG SEQADV 5UIT HIS B 141 UNP Q9NWZ3 EXPRESSION TAG SEQADV 5UIT HIS B 142 UNP Q9NWZ3 EXPRESSION TAG SEQADV 5UIT HIS B 143 UNP Q9NWZ3 EXPRESSION TAG SEQADV 5UIT HIS B 144 UNP Q9NWZ3 EXPRESSION TAG SEQADV 5UIT GLY B 145 UNP Q9NWZ3 EXPRESSION TAG SEQADV 5UIT GLY B 146 UNP Q9NWZ3 EXPRESSION TAG SEQADV 5UIT GLU B 147 UNP Q9NWZ3 EXPRESSION TAG SEQADV 5UIT ASN B 148 UNP Q9NWZ3 EXPRESSION TAG SEQADV 5UIT LEU B 149 UNP Q9NWZ3 EXPRESSION TAG SEQADV 5UIT TYR B 150 UNP Q9NWZ3 EXPRESSION TAG SEQADV 5UIT PHE B 151 UNP Q9NWZ3 EXPRESSION TAG SEQADV 5UIT GLN B 152 UNP Q9NWZ3 EXPRESSION TAG SEQADV 5UIT GLY B 153 UNP Q9NWZ3 EXPRESSION TAG SEQRES 1 A 323 MET HIS HIS HIS HIS HIS HIS GLY GLY GLU ASN LEU TYR SEQRES 2 A 323 PHE GLN GLY GLU ASN LYS SER LEU GLU VAL SER ASP THR SEQRES 3 A 323 ARG PHE HIS SER PHE SER PHE TYR GLU LEU LYS ASN VAL SEQRES 4 A 323 THR ASN ASN PHE ASP GLU ARG PRO ILE SER VAL GLY GLY SEQRES 5 A 323 ASN LYS MET GLY GLU GLY GLY PHE GLY VAL VAL TYR LYS SEQRES 6 A 323 GLY TYR VAL ASN ASN THR THR VAL ALA VAL LYS LYS LEU SEQRES 7 A 323 ALA ALA MET VAL ASP ILE THR THR GLU GLU LEU LYS GLN SEQRES 8 A 323 GLN PHE ASP GLN GLU ILE LYS VAL MET ALA LYS CYS GLN SEQRES 9 A 323 HIS GLU ASN LEU VAL GLU LEU LEU GLY PHE SER SER ASP SEQRES 10 A 323 GLY ASP ASP LEU CYS LEU VAL TYR VAL TYR MET PRO ASN SEQRES 11 A 323 GLY SER LEU LEU ASP ARG LEU SER CYS LEU ASP GLY THR SEQRES 12 A 323 PRO PRO LEU SER TRP HIS MET ARG CYS LYS ILE ALA GLN SEQRES 13 A 323 GLY ALA ALA ASN GLY ILE ASN PHE LEU HIS GLU ASN HIS SEQRES 14 A 323 HIS ILE HIS ARG ASP ILE LYS SER ALA ASN ILE LEU LEU SEQRES 15 A 323 ASP GLU ALA PHE THR ALA LYS ILE SER ASP PHE GLY LEU SEQRES 16 A 323 ALA ARG ALA SER GLU LYS PHE ALA GLN THR VAL MET TPO SEQRES 17 A 323 SEP ARG ILE VAL GLY THR THR ALA TYR MET ALA PRO GLU SEQRES 18 A 323 ALA LEU ARG GLY GLU ILE THR PRO LYS SER ASP ILE TYR SEQRES 19 A 323 SER PHE GLY VAL VAL LEU LEU GLU ILE ILE THR GLY LEU SEQRES 20 A 323 PRO ALA VAL ASP GLU HIS ARG GLU PRO GLN LEU LEU LEU SEQRES 21 A 323 ASP ILE LYS GLU GLU ILE GLU ASP GLU GLU LYS THR ILE SEQRES 22 A 323 GLU ASP TYR ILE ASP LYS LYS MET ASN ASP ALA ASP SER SEQRES 23 A 323 THR SER VAL GLU ALA MET TYR SER VAL ALA SER GLN CYS SEQRES 24 A 323 LEU HIS GLU LYS LYS ASN LYS ARG PRO ASP ILE LYS LYS SEQRES 25 A 323 VAL GLN GLN LEU LEU GLN GLU MET THR ALA SER SEQRES 1 B 323 MET HIS HIS HIS HIS HIS HIS GLY GLY GLU ASN LEU TYR SEQRES 2 B 323 PHE GLN GLY GLU ASN LYS SER LEU GLU VAL SER ASP THR SEQRES 3 B 323 ARG PHE HIS SER PHE SER PHE TYR GLU LEU LYS ASN VAL SEQRES 4 B 323 THR ASN ASN PHE ASP GLU ARG PRO ILE SER VAL GLY GLY SEQRES 5 B 323 ASN LYS MET GLY GLU GLY GLY PHE GLY VAL VAL TYR LYS SEQRES 6 B 323 GLY TYR VAL ASN ASN THR THR VAL ALA VAL LYS LYS LEU SEQRES 7 B 323 ALA ALA MET VAL ASP ILE THR THR GLU GLU LEU LYS GLN SEQRES 8 B 323 GLN PHE ASP GLN GLU ILE LYS VAL MET ALA LYS CYS GLN SEQRES 9 B 323 HIS GLU ASN LEU VAL GLU LEU LEU GLY PHE SER SER ASP SEQRES 10 B 323 GLY ASP ASP LEU CYS LEU VAL TYR VAL TYR MET PRO ASN SEQRES 11 B 323 GLY SER LEU LEU ASP ARG LEU SER CYS LEU ASP GLY THR SEQRES 12 B 323 PRO PRO LEU SER TRP HIS MET ARG CYS LYS ILE ALA GLN SEQRES 13 B 323 GLY ALA ALA ASN GLY ILE ASN PHE LEU HIS GLU ASN HIS SEQRES 14 B 323 HIS ILE HIS ARG ASP ILE LYS SER ALA ASN ILE LEU LEU SEQRES 15 B 323 ASP GLU ALA PHE THR ALA LYS ILE SER ASP PHE GLY LEU SEQRES 16 B 323 ALA ARG ALA SER GLU LYS PHE ALA GLN THR VAL MET TPO SEQRES 17 B 323 SEP ARG ILE VAL GLY THR THR ALA TYR MET ALA PRO GLU SEQRES 18 B 323 ALA LEU ARG GLY GLU ILE THR PRO LYS SER ASP ILE TYR SEQRES 19 B 323 SER PHE GLY VAL VAL LEU LEU GLU ILE ILE THR GLY LEU SEQRES 20 B 323 PRO ALA VAL ASP GLU HIS ARG GLU PRO GLN LEU LEU LEU SEQRES 21 B 323 ASP ILE LYS GLU GLU ILE GLU ASP GLU GLU LYS THR ILE SEQRES 22 B 323 GLU ASP TYR ILE ASP LYS LYS MET ASN ASP ALA ASP SER SEQRES 23 B 323 THR SER VAL GLU ALA MET TYR SER VAL ALA SER GLN CYS SEQRES 24 B 323 LEU HIS GLU LYS LYS ASN LYS ARG PRO ASP ILE LYS LYS SEQRES 25 B 323 VAL GLN GLN LEU LEU GLN GLU MET THR ALA SER MODRES 5UIT TPO A 345 THR MODIFIED RESIDUE MODRES 5UIT SEP A 346 SER MODIFIED RESIDUE MODRES 5UIT TPO B 345 THR MODIFIED RESIDUE MODRES 5UIT SEP B 346 SER MODIFIED RESIDUE HET TPO A 345 11 HET SEP A 346 10 HET TPO B 345 11 HET SEP B 346 10 HET 8CD A 501 46 HET 8CD B 501 46 HETNAM TPO PHOSPHOTHREONINE HETNAM SEP PHOSPHOSERINE HETNAM 8CD 1-{[(2S)-5-OXOPYRROLIDIN-2-YL]METHOXY}-7-[(PROPAN-2- HETNAM 2 8CD YL)OXY]ISOQUINOLINE-6-CARBOXAMIDE HETSYN TPO PHOSPHONOTHREONINE HETSYN SEP PHOSPHONOSERINE FORMUL 1 TPO 2(C4 H10 N O6 P) FORMUL 1 SEP 2(C3 H8 N O6 P) FORMUL 3 8CD 2(C18 H21 N3 O4) FORMUL 5 HOH *454(H2 O) HELIX 1 AA1 SER A 169 THR A 177 1 9 HELIX 2 AA2 PRO A 184 GLY A 188 5 5 HELIX 3 AA3 THR A 223 CYS A 240 1 18 HELIX 4 AA4 SER A 269 CYS A 276 1 8 HELIX 5 AA5 LEU A 277 THR A 280 5 4 HELIX 6 AA6 SER A 284 ASN A 305 1 22 HELIX 7 AA7 LYS A 313 ALA A 315 5 3 HELIX 8 AA8 THR A 351 MET A 355 5 5 HELIX 9 AA9 ALA A 356 ARG A 361 1 6 HELIX 10 AB1 PRO A 366 GLY A 383 1 18 HELIX 11 AB2 LEU A 395 LEU A 397 5 3 HELIX 12 AB3 ASP A 398 ASP A 405 1 8 HELIX 13 AB4 THR A 409 ILE A 414 1 6 HELIX 14 AB5 ASP A 422 LEU A 437 1 16 HELIX 15 AB6 LYS A 440 ARG A 444 5 5 HELIX 16 AB7 ASP A 446 THR A 458 1 13 HELIX 17 AB8 SER B 169 THR B 177 1 9 HELIX 18 AB9 PRO B 184 GLY B 188 5 5 HELIX 19 AC1 THR B 223 CYS B 240 1 18 HELIX 20 AC2 SER B 269 CYS B 276 1 8 HELIX 21 AC3 LEU B 277 THR B 280 5 4 HELIX 22 AC4 SER B 284 ASN B 305 1 22 HELIX 23 AC5 LYS B 313 ALA B 315 5 3 HELIX 24 AC6 THR B 351 MET B 355 5 5 HELIX 25 AC7 ALA B 356 ARG B 361 1 6 HELIX 26 AC8 THR B 365 GLY B 383 1 19 HELIX 27 AC9 LEU B 395 LEU B 397 5 3 HELIX 28 AD1 ASP B 398 ASP B 405 1 8 HELIX 29 AD2 THR B 409 ILE B 414 1 6 HELIX 30 AD3 ASP B 422 LEU B 437 1 16 HELIX 31 AD4 LYS B 440 ARG B 444 5 5 HELIX 32 AD5 ASP B 446 THR B 458 1 13 SHEET 1 AA1 6 HIS A 166 SER A 167 0 SHEET 2 AA1 6 LEU A 248 SER A 252 1 O LEU A 249 N HIS A 166 SHEET 3 AA1 6 CYS A 259 VAL A 263 -1 O VAL A 261 N LEU A 249 SHEET 4 AA1 6 THR A 208 LYS A 214 -1 N LYS A 213 O LEU A 260 SHEET 5 AA1 6 VAL A 199 VAL A 205 -1 N TYR A 201 O VAL A 212 SHEET 6 AA1 6 LYS A 191 GLU A 194 -1 N MET A 192 O VAL A 200 SHEET 1 AA2 2 HIS A 307 ILE A 308 0 SHEET 2 AA2 2 ARG A 334 ALA A 335 -1 O ARG A 334 N ILE A 308 SHEET 1 AA3 2 ILE A 317 LEU A 319 0 SHEET 2 AA3 2 ALA A 325 ILE A 327 -1 O LYS A 326 N LEU A 318 SHEET 1 AA4 2 VAL A 343 MET A 344 0 SHEET 2 AA4 2 GLU A 363 ILE A 364 -1 O ILE A 364 N VAL A 343 SHEET 1 AA5 6 HIS B 166 SER B 167 0 SHEET 2 AA5 6 LEU B 248 SER B 253 1 O LEU B 249 N HIS B 166 SHEET 3 AA5 6 LEU B 258 VAL B 263 -1 O VAL B 261 N LEU B 249 SHEET 4 AA5 6 THR B 208 LEU B 215 -1 N LYS B 213 O LEU B 260 SHEET 5 AA5 6 GLY B 198 VAL B 205 -1 N TYR B 201 O VAL B 212 SHEET 6 AA5 6 LYS B 191 GLU B 194 -1 N MET B 192 O VAL B 200 SHEET 1 AA6 2 HIS B 307 ILE B 308 0 SHEET 2 AA6 2 ARG B 334 ALA B 335 -1 O ARG B 334 N ILE B 308 SHEET 1 AA7 2 ILE B 317 LEU B 319 0 SHEET 2 AA7 2 ALA B 325 ILE B 327 -1 O LYS B 326 N LEU B 318 SHEET 1 AA8 2 VAL B 343 MET B 344 0 SHEET 2 AA8 2 GLU B 363 ILE B 364 -1 O ILE B 364 N VAL B 343 LINK C MET A 344 N TPO A 345 1555 1555 1.33 LINK C TPO A 345 N SEP A 346 1555 1555 1.34 LINK C SEP A 346 N ARG A 347 1555 1555 1.34 LINK C MET B 344 N TPO B 345 1555 1555 1.33 LINK C TPO B 345 N SEP B 346 1555 1555 1.34 LINK C SEP B 346 N ARG B 347 1555 1555 1.35 CISPEP 1 GLU A 392 PRO A 393 0 -2.69 CISPEP 2 GLU B 392 PRO B 393 0 -2.26 SITE 1 AC1 13 MET A 192 GLU A 194 ALA A 211 TYR A 262 SITE 2 AC1 13 VAL A 263 TYR A 264 MET A 265 ALA A 315 SITE 3 AC1 13 ASN A 316 LEU A 318 SER A 328 HOH A 629 SITE 4 AC1 13 HOH A 675 SITE 1 AC2 13 MET B 192 GLU B 194 ALA B 211 TYR B 262 SITE 2 AC2 13 VAL B 263 TYR B 264 MET B 265 ALA B 315 SITE 3 AC2 13 ASN B 316 LEU B 318 SER B 328 HOH B 612 SITE 4 AC2 13 HOH B 643 CRYST1 91.140 118.580 139.630 90.00 90.00 90.00 I 2 2 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010972 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008433 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007162 0.00000